Beyond MRSA: VISA and VRSA. What will ward off these pathogens in health care facilities?

American Journal of Nursing

Volumn 106, Issue 4, 2006, Pages 28-30

  Todd, Betsy ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645470421     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200604000-00021     Document Type: Short Survey

References (15)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32(8):470-85.
2. Ploy MC, et al. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998;351(9110):1212.
3. Centers for Disease Control and Prevention. frequently asked questions about VISA/VRSA. 2003 Apr. http://www.cdc.gov/ncidod/dhqp/ar_visavrsa_FAQ.html.
4. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51(26):565-7.
5. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002;51(40):902.
6. Vancomycin-resistant Staphylococcus aureus - New York, 2004. MMWRMorb Mortal Wkly Rep 2004;53(15):322-3.
7. Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing: fifteenth informational supplement. Wayne, PA: The Institute; 2005. Document M100-S15.
8. Tsiodras S, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001;358(9277):207-8.
9. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001;32(1):108-15.
10. Bozdogan B, et al. Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center. Antimicrob Agents Chemother 2004;48(12):4762-5.
11. Wenzel RP, Edmond MB. Vancomycin-resistant Staphylococcus aureus: infection control considerations. Clin Infect Dis 1998;27(2):245-9.
12. Kirst HA, et al. Historical yearly usage of vancomycin. Antimicrob Agents Chemother 1998;42(5): 1303-4.
13. Vicca AF. Nursing staff workload as a determinant of methicillin- resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 1999;43(2):109-13.
14. Farringtoni M, et al. Effects on nursing workload of different methicillin-resistant Staphylococcus aureus (MRSA) control strategies. J Hosp Infect 2000;46(2):118-22.
15. Jackson M, et al. Nurse staffing and health care-associated infections: proceedings from a working group meeting. Am J Infect Control 2002;30(4):199-206.